Structure-based computational approach for optimizing oligonucleotides for A-to-I editing Poster Applicability of a structure-based modelling approach as a tool for in silico screening of oligonucleotides for targeted RNA editing presented at Oligonucleotide Therapeutics Society (OTS) 2018 by Julien Boudet September 30, 2018
ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology Press release Key updates September 21, 2017
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update Press release Key updates February 28, 2017
ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences Press release LEIDEN, Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 01, 2015
ProQR to Present at Scientific and Investor Conferences in September Press release LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 06, 2016
ProQR Announces Presentations at the OTS Annual Meeting Press release LEIDEN, the Netherlands, Sept. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 24, 2018
ProQR Announces Financial Results for the Third Quarter of 2018 Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 07, 2018
ProQR Announces Results for the Third Quarter of 2016 Press release LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 14, 2016
